171 related articles for article (PubMed ID: 22698421)
1. Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies.
Liu CF; Zhou WN; Fang NY
Int J Clin Pract; 2012 Jul; 66(7):692-8. PubMed ID: 22698421
[TBL] [Abstract][Full Text] [Related]
2. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
André P; Balkau B; Vol S; Charles MA; Eschwège E;
Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies.
Du G; Song Z; Zhang Q
Prev Med; 2013 Jul; 57(1):31-7. PubMed ID: 23571185
[TBL] [Abstract][Full Text] [Related]
5. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis.
Liu CF; Gu YT; Wang HY; Fang NY
PLoS One; 2012; 7(11):e48878. PubMed ID: 23145005
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of gamma glutamyltransferase and obesity on metabolic syndrome, independent of hepatic steatosis.
Hwang AC; Lin YC; Liu PT; Kao YM; Chen JD
Ann Epidemiol; 2012 Dec; 22(12):876-80. PubMed ID: 23110960
[TBL] [Abstract][Full Text] [Related]
8. Association between serum gamma-glutamyltransferase and acute ischemic nonembolic stroke in elderly subjects.
Korantzopoulos P; Tzimas P; Kalantzi K; Kostapanos M; Vemmos K; Goudevenos J; Elisaf M; Milionis H
Arch Med Res; 2009 Oct; 40(7):582-9. PubMed ID: 20082873
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
10. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
11. Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis.
Kunutsor SK; Apekey TA; Seddoh D
Int J Clin Pract; 2015 Jan; 69(1):136-44. PubMed ID: 25363194
[TBL] [Abstract][Full Text] [Related]
12. Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population.
Lee MY; Koh SB; Koh JH; Nam SM; Shin JY; Shin YG; Kong ID; Ryu SY; Lee TY; Park JK; Chung CH
Diabet Med; 2008 Apr; 25(4):469-75. PubMed ID: 18346161
[TBL] [Abstract][Full Text] [Related]
13. Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome.
Giral P; Jacob N; Dourmap C; Hansel B; Carrié A; Bruckert E; Girerd X; Chapman MJ
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):587-93. PubMed ID: 18202323
[TBL] [Abstract][Full Text] [Related]
14. Association of serum gamma-glutamyltransferase with chronic kidney disease risk: a meta-analysis.
Fan Y; Jin X; Man C; Gong D
Free Radic Res; 2018 Aug; 52(8):819-825. PubMed ID: 30208797
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic enzymes and lipid peroxidation in patients with metabolic syndrome.
De Bona KS; Bonfanti G; Cargnelutti LO; Bitencourt PE; da Silva PS; Ceolin R; Pimentel VC; Moretto MB
Clin Biochem; 2012 Sep; 45(13-14):1081-5. PubMed ID: 22709933
[TBL] [Abstract][Full Text] [Related]
16. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease.
Devers MC; Campbell S; Shaw J; Zimmet P; Simmons D
Diabet Med; 2008 May; 25(5):523-9. PubMed ID: 18346165
[TBL] [Abstract][Full Text] [Related]
17. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults.
Kang YH; Min HK; Son SM; Kim IJ; Kim YK
Diabetes Res Clin Pract; 2007 Aug; 77(2):306-13. PubMed ID: 17353063
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum gamma-glutamyltransferase levels between patients with cardiac syndrome X and healthy asymptomatic individuals.
Demir B; Temizhan A; Keskin G; Baser K; Turak O; Cay S
Kardiol Pol; 2012; 70(1):31-7. PubMed ID: 22267422
[TBL] [Abstract][Full Text] [Related]
19. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study.
Van Hemelrijck M; Jassem W; Walldius G; Fentiman IS; Hammar N; Lambe M; Garmo H; Jungner I; Holmberg L
Eur J Cancer; 2011 Sep; 47(13):2033-41. PubMed ID: 21486691
[TBL] [Abstract][Full Text] [Related]
20. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
